Download Files:
Tesaglitazar
SKU
HY-17444-10 mg
Category Reference compound
Tags Cancer; Metabolic Disease, Cell Cycle/DNA Damage;Vitamin D Related/Nuclear Receptor, PPAR
$110 – $960
Products Details
Product Description
– Tesaglitazar is a dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist that is more potent on PPARγ than on PPARα, with EC50s of 13.4 μM and 3.6 μM for rat PPARα and human PPARα, respectively, and approximately 0.2 μM for both rat and human PPARγ. Tesaglitazar induces interstitial mesenchymal cell DNA synthesis and fibrosarcomas in subcutaneous tissues in rats[1].
Web ID
– HY-17444
Storage Temperature
– -20°C (Powder, sealed storage, away from moisture)
Shipping
– Blue Ice
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C20H24O7S
References
– [1]Hellmold H, et al. Tesaglitazar, a PPARalpha/gamma agonist, induces interstitial mesenchymal cell DNA synthesis and fibrosarcomas in subcutaneous tissues in rats. Toxicol Sci. 2007 Jul;98(1):63-74.
CAS Number
– 251565-85-2
Molecular Weight
– 408.47
Compound Purity
– 99.18
SMILES
– O=C(O)[C@@H](OCC)CC1=CC=C(OCCC2=CC=C(OS(=O)(C)=O)C=C2)C=C1
Clinical Information
– Phase 3
Research Area
– Cancer; Metabolic Disease
Solubility
– DMSO : 200 mg/mL (ultrasonic;warming;heat to 60°C)
Target
– PPAR
Pathway
– Cell Cycle/DNA Damage;Vitamin D Related/Nuclear Receptor
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.